Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardene I.V. in Pediatric Hypertension
NCT00528827Phase 2Withdrawn
- Sponsor
- Facet Biotech Corporation
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nicardipine in hypertension (HTN) (4 arms), sponsored by Facet Biotech Corporation. Primary endpoint: Mean percent change in Systolic Blood Pressure from baseline at 30 minutes. Planned start Sep 2007; status: withdrawn.
02
Drugs
nicardipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00528827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528827.